Previous view was $16.90-$17.85. Sees FY23 revenue $3.725B-$3.875B, consensus $3.78B. Previous guidance was $3.675B-$3.875B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on JAZZ:
- Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance
- JAZZ Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- 5 Healthcare Stocks to Buy Now, According to Analysts – August 2023
- Jazz Pharmaceuticals Canada enters into LoI with pCPA for Rylaze
- Jazz announces the EMA’s CHMP adopted a positive opinion for JZP458